SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
1-Year Return
17.43%
This Quarter Return
-4.12%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.33B
AUM Growth
-$38.3M
(-2.8%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
54.83%
Holding
78
New
15
Increased
20
Reduced
13
Closed
16
Top Buys
| 1 |
Stryker
SYK
|
$68M |
| 2 |
Medtronic
MDT
|
$50.6M |
| 3 |
Eli Lilly
LLY
|
$31.7M |
| 4 |
PTC Therapeutics
PTCT
|
$29.5M |
| 5 |
IDEAYA Biosciences
IDYA
|
$25.4M |
Top Sells
| 1 |
AbbVie
ABBV
|
$63.9M |
| 2 |
AstraZeneca
AZN
|
$42.7M |
| 3 |
Gilead Sciences
GILD
|
$39.8M |
| 4 |
Axsome Therapeutics
AXSM
|
$36.9M |
| 5 |
Boston Scientific
BSX
|
$31M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Alkermes
ALKS
$4.94B
| – | – |
-894,266
| Closed | -$25.7M |
|
77
Avantor
AVTR
$9.07B
| – | – |
-200,000
| Closed | -$4.21M |
|
|
78
AstraZeneca
AZN
$253B
| – | – |
-651,344
| Closed | -$42.7M |
|